1. Samples of portal venous and femoral arterial plasma and mesenteric lymph were collected from unanaesthetized rats before and during the intra-duodenal infusion of high concentrations (100 mmoljl) of glycine or glycine oligopeptides (up to and including tetraglycine).
It is generally agreed that proteins are completely hydrolysed to their constituent amino acids before they are absorbed into portal blood (Christensen, Decker, Lynch, Mackenzie & Powers, 1947; Dent & Schilling, 1949; Parshin & Rubel, 1951; Stein & Moore, 1954; Dawson & Holdsworth, 1962) . It is a matter of controversy, however, at what site the peptides released by gastric and pancreatic digestion are finally hydrolysed to their constituent amino acids. Some workers believe that peptide hydrolysis is solely a function of the brush border (Kushak & Ugolev, 1966; Rhodes, Eichholz & Crane, 1967; Fern, Hider & London, 1969) , whereas others consider that oligopeptides are hydrolysed at the brush border to yield free amino acids and dipeptides and that the latter are hydrolysed within the enterocyte (Friedrich, Noack & Schenk, 1965; Peters, 1968; Peters, Modha & MacMahon, 1969) . This second hypothesis would imply that dipeptides are transported across the brush border membrane and indeed in vitro studies have indicated that they can be absorbed into the epithelial cell and that small Correspondence: Dr T. J. Peters amounts may even emerge from the serosal aspect of the mucosa (Agar, Hird & Sidhu, 1953; Wiggans & Johnston, 1959; Newey & Smyth, 1960) .
The present study was undertaken to determine whether glycylglycine can pass intact across the intestinal mucosa in the unanaesthetized rat, and whether this 'translocation is limited to dipeptides or if triglycine and tetraglycine can also pass directly into portal blood. In addition. studies were performed to determine whether any of these peptides can enter mesenteric lymph.
METHODS

Operative procedures
Male Wistar rats weighing between 250 and 300 g were anaesthetized with intraperitoneal pentobarbitone 35 mg/kg.
Splenectomy. Splenectomy was performed in order to reduce the portal blood flow from sources other than the small intestine. It was performed through a small left subcostal incision; the terminal branches of the splenic artery were ligated together with their accompanying veins, close to the splenic hilum.
Mesenteric lymphatic cannulation. The mesenteric lymphatic cannulation, duodenal intubation and portal vein cannulation were all performed through a right subcostal incision. The main lymphatic vessel was cannulated by a modification of the method of Bollman, Cain & Grindlay (1948) . The rat was placed over a small bridge to givebetter exposure of the root of the mesentery. The superior mesenteric artery was identified and the main lymphatic vessel located alongside the artery. After carefully dissecting the mesenteric lymphatic free of fascia and peritoneum, a polythene cannula (portex pp 25, external diameter 0·80 mm, internal diameter 0·40 mm) was inserted into the vessel and anchored to the root of the mesentery by a stay suture. Small lymphatic channels which did not drain into the main duct were ruptured and in order to stop leakage of the lymph from these vessels and from around the cannulation site a drop of strongly contracting, quick-drying adhesive (Eastman 910 adhesive) was put on the area.
Portal vein cannulation. The surface of the portal vein approximately 1 em from the porta hepatis was roughened with a needle and a sharply bevelled polythene cannula (portex pp 25) was pushed through this area into the lumen. Generally very little bleeding occurred and the cannula was fixed in position with Eastman 910 adhesive and by a stay suture to the adjoining mesentery. This technique was found to be more satisfactory than that of Hyun, Vahouny & Treadwell (1967) who cannulated the portal vein via the splenic vein.
Femoral artery cannulation. This was performed using a very fine cannula (Portex pp 100, external diameter 0·61 mm, internal diameter 0·28 mm) which was advanced until the tip was in the abdominal aorta.
Duodenal intubation. A PVC cannula (Portex No 1, external diameter 1·44 mm, internal diameter 0·63 mm) was inserted through a small incision 2 em from the pylorus and secured by a purse-string suture.
Post-operative care. After suture of the incision the animals were placed in restraining cages similar to those described by Bollman (1948) . The rats were allowed to recover overnight before study and were allowed free access to a solution of glucose (4,3 % w/v) and sodium chloride (0'18 %w/v) by mouth. The portal and femoral cannulae were kept patent by infusion into each vessel of heparinized saline (2,5 units/ml in 0·15 M NaCl) at 1 ml/h.
Ion-exchange chromatography
Sample preparation. 2 ml samples of portal venous or femoral arterial blood were collected at timed intervals by an exchange-transfusion technique. Blood was collected from anaesthetized donor animals via the abdominal aorta and mixed with approximately one fifth volume of acid-citrate-dextrose (3 g glucose, 2 g disodium hydrogen citrate, water to 120 ml; Loutit & Mollison, 1943) and was stored at 4°for up to 1 week. It was warmed to room temperature before use. The 2 ml samples were withdrawn over a period of 1 min into heparinized syringes and 2 ml of donor blood infused over the subsequent minute. There were no untoward reactions to the transfusion. The plasma was separated by centrifugation at 3000 g for 20 min at 4°. The plasma and lymph were deproteinized by acidification to pH 1·5 and ultracentrifugation (Gerritsen, Rehberg & Waisman, 1965) and were stored at -20°until analysis. Urine was acidified to pH 1·5 by addition of the internal standard solution and analysed directly.
Chromatography. Separation and quantitation of the glycine and glycine peptides was performed using a Technicon Amino Acid Analyser. The 'B' type resin in a 140 em column was maintained at 65°through the analysis. After regeneration with 0·2 M NaOH the resin was equilibrated with sodium citrate buffer pH = 3,40, 1= O·2, containing 1 mmoljl Na 4 EDTA, 0·1 % Brij 35 solution (30% wjv) and 0·1 % phenol. The sample was loaded in 12'5% sucrose and was eluted using the same buffer. The internal standard was 0·1 /lmol alpha-amino n butyric acid and integration of the peaks was performed by triangulation. A proportion of the column effluent (10 %) was collected in a fraction collector in 10 min aliquots. The fractions corresponding to the diglycine peak were pooled and desalted by the method of Thompson, Morris & Gering (1959) . Thin layer chromatography was performed using the following solvent systems: n butanol: acetic acid:water (80 :20: 2, vjvjv) and phenol: water (75:25, wjv). Colour development was performed by spraying the dried plates with 0·17 % ninhydrin in absolute ethanol: glacial acetic acid (80:20 vjv).
Infusion technique
During an initial 30 min control period, 0·15 M NaCl was infused intraduodenally at about 12 mljh, and samples oflymph, urine, portal, venous and femoral arterial blood taken, although not necessarily all from the same animal. The amino acid or peptides were infused during the next 30 min period and 0'15 M NaCl was infused for the following 30 min. The animals were allowed free access to water. Urine and lymph were collected in 1 h periods for 3 h following the infusion, and samples of blood were taken at 30-60 min intervals. Fig. 1 shows the traces of two chromatograms of portal venous plasma collected from a rat before and during the infusion of 100 mmoljl triglycine. The fasting plasma (upper trace) shows several unidentified amino acid or peptide peaks labelled Q, R, S, T, U, Y, X and Y, a small amount of free glycine and the internal standard, alpha-amino n butyric acid. The plasma . collected during the infusion (lower trace) shows increased amounts of these unidentified components, particularly Sand T, and a marked increase in the concentration of glycine. A new peak is present, emerging after the compounds X and Y. This peak was identified as diglycine as follows: (i) The time of elution, from the column 200-210 min, was similar to that for diglycine (Table 1 ) but differed markedly from that of other glycine peptides.
RESULTS
Analysis ofportal venous and femoral arterial blood
(ii) The material was shown to chromatograph identically with diglycine. Fig. 2 shows parts of three chromatograms; the upper trace is of a sample of portal blood collected during the intraduodenal infusion oftetraglycine, the middle trace is of the same sample of blood to which Q. I Ilmol ofdiglycine has been added and the lower trace is of the same sample of blood to which O'I pmol of triglycine has been added. The unknown peak coincides with that of diglycine, (iii) By the use of specific enzyme activators and inhibitors it is possible to use intestinal homogenates as a source of diglycine peptidase or of triglycine peptidase. The dipeptidase is strongly activated by I mmol/l C0 2 + ions (Berger & Johnson, 1939; Smith, 1948; Robinson, 1963; Josefsson & Lindberg, 1965) but is almost completely inhibited by EDTA (Robinson, Birnbaum & Greenstein, 1953; Smith, 1955a) . On the other hand, tripeptidase which has no activity against dipeptides or tetrapeptides (Davis & Smith, 1955 ) is unaffected by C0 2 + ions and is resistant to the inhibitory effect of 5 mmol/I EDTA (Ellis & Fruton, 1951; Smith, 1955b) . Table 2 shows the unknown peak after incubation with di-or tri-peptidase. The tri-peptidase had no effect, but the peak was almost completely hydrolysed by dipeptidase.
(iv) After isolation ofthis material by column chromatography, it behaved like diglycine on thin-layer chromatography and yielded two equivalents of glycine on complete acid hydrolysis. Table 3 shows the concentration of glycine and diglycine in the portal plasma of rats before and 30 min after starting the intraduodenal infusion of 100 mmolJI glycine, diglycine, triglycine or tetraglycine. The fasting portal plasma concentration ofglycinewas 0·23 -0'32 mmolJI; no diglycine, triglycine or tetraglycine was detected. Plasma analysed 30 min after starting the infusion showed a marked rise (approximately lO-fold) in concentration of glycine. There was a significant amount of diglycine (approximately 1/20th of the glycine concentration) in the plasma when the peptides were infused, but no diglycine was detected when the free amino acid was infused. No tri-or tetra-glycine was detected in the portal blood when these peptides were infused. The glycine and diglycine were also detected in femoral artery plasma but at concentrations slightly lower than that in portal plasma. It is not possible to draw firm conclusions from the relative concentrations of glycine and diglycine in portal plasma after infusion of the different peptides because the actual concentration of the compounds in the plasma is dependent on many variables. However, it is of interest to note that the highest concentration of glycine was found during the infusion of the tripeptide but the highest concentration of diglycine was found during the tetrapeptide infusion.
The diglycine was absent from both portal and arterial plasma collected 60 min or more after stopping the peptide infusion; no peptide was detected in the urine of any animal studied, indicating that the peptide is not cleared from the blood by urinary excretion.
In a single experiment in which 10 mmoljl diglycine was infused intraduodenally under the same experimental conditions as described previously, the portal venous plasma glycine increased from 0·27 mmoljl to 0·68 mmoljl. A small amount of diglycine (0'02 mmoljl) was also detected. Fig. 3 shows the detailed results from a single rat infused with 100 mmoljl triglycine. In this animal both portal venous and femoral arterial cannula were present. Samples of urine were also analysed. The animal was infused intraduodenally with 500 pmol triglycine over a 30 min period. There was a marked rise in both portal venous (16-fold) and in femoral arterial (12-fold) glycine concentration after the period of infusion. This rapidly declined over the subsequent 90 min. The concentration of diglycine in both femoral and portal plasma reached a peak at 30 min and then rapidly declined; the concentration of peptide and of free amino acid was higher in portal plasma than in femoral plasma, at all times throughout the experiment. The urine glycine concentration rose lO-fold during the period of study. Table 4 shows the concentration of glycine and diglycine in mesenteric lymph from rats before, during and after the infusion of 100mmolJl glycine, diglycine and triglycine. The fasting concentration of glycine in lymph (0'31 mmol/l) was similar to that in portal plasma (0,27 mmol/l). During the infusion of glycine or the peptides there was a marked rise in the glycine concentrations, and it was noteworthy that the glycine concentration was highest after the infusion of the tripeptide. During the infusion of glycine no diglycine was detected; during the infusion of the peptides only diglycine and glycine were detected; findings analogous to those of portal blood.
Analysis oflymph
It is possible to calculate approximately the amount of glycine collected from the mesenteric lymphatic during the experimental period. During and after the infusion of glycine, diglycine and triglycine the respective amounts of glycine collected were 6, 17 and 24 jlmol. These figures represent approximately 1 %of the infused glycine. 
DISCUSSION
This paper shows that when a series of glycine peptides, up to and including tetraglycine, were infused into the duodenum of the rat there was a marked rise in glycine concentration and a smaller rise in diglycine concentration in portal plasma. No other glycine oligopeptides were detected in either portal or systemic plasma. No peptide was detected when free glycine was infused, indicating that the diglycine was of exogenous origin and not synthesized from glycine by the intestinal mucosa. Although direct comparison of portal plasma and mesenteric lymph is not possible, the data shown in Tables 3 and 4 indicate that similar concentrations of both glycine and diglycine are found in the two fluids, suggesting that the lymph behaves as a dialysate of plasma and that there is no specific transport of peptide or amino acid by the lymph as has been postulated by Fisher (1967) . The portal plasma flow of approximately 10 ml/min (Ross, White, Brown & Kolin, 1966) compared to the lymph flow of 1-2 ml/h also suggests that it is unlikely that this latter route is an important source of nitrogen transport.
The maximal concentrations of glycine in portal plasma occurred from tripeptide, a finding consistent with those of Matthews, Craft, Geddes, Wise & Hyde (1968) who showed that the rate of glycine absorption from a series of glycine oligopeptides up to and including tetraglycine, was maximal from the triglycine.
As far as we are aware, there has been only one previous study on the transfer of triglycine and tetraglycine across the intestinal wall. Agar, Hird & Sidhu (1954) studied the transport and hydrolysis of a series of glycine oligopeptides up to and including tetraglycine by the isolated perfused intestine, and showed that glycine and a small amount of diglycine entered the serosal fluid. No higher glycine peptides were detected, findings similar to the present study. The observation that only the dipeptide is detected in portal blood is of interest with respect to current theories on the site of peptide hydrolysis. It has been suggested that dipeptides are hydrolysed within the cytosol of the enterocyte but that longer peptides are cleaved sequentially to dipeptides and free amino acids at the brush border (peters, 1968; Peters et al., 1969; Peters, Modha & Drey, to be published). The present studies support this hypothesis. The tri-and tetraglycine would be expected to be hydrolysed to free glycine and diglycine at the brush border. The dipeptide would be transported into the cytoplasm of the enterocyte where the final stage of hydrolysis occurs. Presumably a small proportion of the diglycine (less than 10%) passes directly to the portal capillaries, perhaps via the intercellular spaces. It is unlikely that the failure to hydrolyse the diglycine completely is due to a relative mucosal deficiency of dipeptidase as compared to tripeptidase, since it has been shown that dipeptidase activity is several times higher than tripeptidase activity (Friedrich et al., 1965; Wall & Peters, unpublished) . Recent studies by Milne and his colleagues also support the suggestion that dipeptide transport into the intestinal epithelial cell precedes dipeptide hydrolysis (Navab & Asatoor, 1970; Asatoor, Bandoh, Lant, Milne & Navab, 1970a; Asatoor, Cheng, Edward, Lant, Mathews, Milne, Navab & Richards, 1970b) .
The increase in amino acid concentration in femoral arterial blood is similar to that in portal blood, an observation first made by van Slyke & Meyer (1912) . The slight difference in concentration between portal and femoral blood is probably due to both peripheral and hepatic clearance of peptide and amino acid. The unidentified components which increase in concentration after the infusion of the glycine or glycine peptides are most probably amino acids. From their elution times they are likely to include alanine and the acidic amino acids. Craft, Geddes, Hyde, Wise & Matthews (1968) noted a rise in the concentration of aspartic acid, glutamic acid, serine and alanine as well as glycine in peripheral venous blood following the administration of glycine or glycine peptides to man.
No peptide was detected in urine indicating that the diglycine was cleared from the circulation by the body tissues rather than by the renal excretion. This is in keeping with the observations that many tissues including liver (Hanson & Blech, 1959; Rademaker & Soons, 1957) , kidney (Hanson & Blech, 1959; Robinson et al., 1953; Capobianco & Vescia, 1967) , skeletal muscle (Schwartz, 1953; Smith, 1948; Pina, Hamabata & Laguna, 1962) , uterus (Smith, 1948) and brain (Uzman, Rumley & van -de Noort, 1961) , contain significant amounts of glycylglycine peptide hydrolase.
